Assessment of the Usefulness of Red Cell Indices as a Screening Tool in Haemoglobin E Trait: A Cross Sectional Study

Dassanayake Dmhmk, Gunawardena Vcp, Athauda Sb
{"title":"Assessment of the Usefulness of Red Cell Indices as a Screening Tool in Haemoglobin E Trait: A Cross Sectional Study","authors":"Dassanayake Dmhmk, Gunawardena Vcp, Athauda Sb","doi":"10.23937/2469-5696/1410069","DOIUrl":null,"url":null,"abstract":"Background: HamoglobinE (HbE) is the second commonest structural haemoglobin variant and results from mutation in the β globin gene causing substitution of glutamic acid for lysine at position 26 of the β globin chain. When coinherited with β Thalassemia it becomes a major health burden. Objective: To assess the effectiveness of red cell parameters as a screening tool to identify haemoglobin E traits and to develop a score using red cell parameters which help to identify Haemoglobin E traits in population screening. Materials and methods: The study was carried out on 25 Haemoglobin E trait and 25 controls between 20 to 64 years of age. In all the participants’ full blood count analysis and Haemoglobin variant analysis were done. Participants were selected after excluding all factors which affect red cell indices such as iron deficiency, vitamin B12 and folate deficiency, pregnancy, liver disease, hypothyroidism, chronic alcohol consumption, Diabetes mellitus, Metformin treatment and recent blood transfusion. Comparative analysis of all haematological parameters done between two groups separately for males and females. Results: For cases of Haemoglobin E traits the overall mean Haemoglobin A was 67.9 ± 6.4%, Haemoglobin E 27.3 ± 3.7%, Haemoglobin F 0.3 ± 1.1%, Haemoglobin A2 2.6 ± 3.1%, RCC 5.03 ± 0.89 × 1012/L, Haemoglobin 12.6 ± 1.9 g/dl, MCV 77.4 ± 9.4 fl, MCH 25.4 ± 3.9 pg, MCHC 32.9 ± 2.1 g/dl, RDW 14.21 ± 4%. Between Haemoglobin E traits and normal controls following haematological parameters showed statistically significant difference. Haemoglobin E (p = 4.83 × 10-53), Haemoglobin A (p = 2.61 × 10-41), Haemoglobin F (p = 0.01), Haemoglobin (p = 0.042), Red cell count (p = 0.001), MCV (p = 4.890 × 10-12), MCH (p = 5.5 x 10-13), RDW (p = 0.007). Haemoglobin E percentage showed statistically significant positive correlation with following red cell parameters. Hb E and Red cell count (r = 0.445, t test 0.001), Hb E and Red cell distribution width (r = 0.345, t test 0.014). Haemoglobin E percentage showed statistically significant negative correlation with following indices. Hb E and MCV (r = (-) 0.76, t test 0.000) Hb E and MCH (r = (-)719, t test 0.000). Correlation of Haemoglobin E percentage with MCHC and Haemoglobin were not statistically significant (r = (-) 0.251, t test 0.078) and (r = (-)0.116, t test 0.424). In addition Hb E percentage negatively correlated with Hb A percentage (r = (-)0.917, t test 0.000) and positively correlated with Hb A2 percentage (r = 0.286, t test 0.044), and Hb F percentage (r = 0.366, t test 0.009). Sensitivity of a score as above to select patients for screening, using a cut off score of 2 or above for females and a score of 3 or above for males was 84%. Specificity was 100%. This is higher than if using the current criteria. If people with red cell count > 5 × 1012/L were also selected sensitivity would increase up to 84%, and negative predictive value to 86%. Conclusion: Even when MCV and MCH are normal, people should be screened to exclude haemoglobin E hetrozygosity, if red cell count or RDW is higher than the reference range for the age. Furthermore, clinicians can apply a score as defined above and select patients for screening. Therefore a screening tool using red cell parameters would be cost effective in hospital settings as well as for mass screening programmes.","PeriodicalId":92793,"journal":{"name":"International journal of blood research and disorders","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International journal of blood research and disorders","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.23937/2469-5696/1410069","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: HamoglobinE (HbE) is the second commonest structural haemoglobin variant and results from mutation in the β globin gene causing substitution of glutamic acid for lysine at position 26 of the β globin chain. When coinherited with β Thalassemia it becomes a major health burden. Objective: To assess the effectiveness of red cell parameters as a screening tool to identify haemoglobin E traits and to develop a score using red cell parameters which help to identify Haemoglobin E traits in population screening. Materials and methods: The study was carried out on 25 Haemoglobin E trait and 25 controls between 20 to 64 years of age. In all the participants’ full blood count analysis and Haemoglobin variant analysis were done. Participants were selected after excluding all factors which affect red cell indices such as iron deficiency, vitamin B12 and folate deficiency, pregnancy, liver disease, hypothyroidism, chronic alcohol consumption, Diabetes mellitus, Metformin treatment and recent blood transfusion. Comparative analysis of all haematological parameters done between two groups separately for males and females. Results: For cases of Haemoglobin E traits the overall mean Haemoglobin A was 67.9 ± 6.4%, Haemoglobin E 27.3 ± 3.7%, Haemoglobin F 0.3 ± 1.1%, Haemoglobin A2 2.6 ± 3.1%, RCC 5.03 ± 0.89 × 1012/L, Haemoglobin 12.6 ± 1.9 g/dl, MCV 77.4 ± 9.4 fl, MCH 25.4 ± 3.9 pg, MCHC 32.9 ± 2.1 g/dl, RDW 14.21 ± 4%. Between Haemoglobin E traits and normal controls following haematological parameters showed statistically significant difference. Haemoglobin E (p = 4.83 × 10-53), Haemoglobin A (p = 2.61 × 10-41), Haemoglobin F (p = 0.01), Haemoglobin (p = 0.042), Red cell count (p = 0.001), MCV (p = 4.890 × 10-12), MCH (p = 5.5 x 10-13), RDW (p = 0.007). Haemoglobin E percentage showed statistically significant positive correlation with following red cell parameters. Hb E and Red cell count (r = 0.445, t test 0.001), Hb E and Red cell distribution width (r = 0.345, t test 0.014). Haemoglobin E percentage showed statistically significant negative correlation with following indices. Hb E and MCV (r = (-) 0.76, t test 0.000) Hb E and MCH (r = (-)719, t test 0.000). Correlation of Haemoglobin E percentage with MCHC and Haemoglobin were not statistically significant (r = (-) 0.251, t test 0.078) and (r = (-)0.116, t test 0.424). In addition Hb E percentage negatively correlated with Hb A percentage (r = (-)0.917, t test 0.000) and positively correlated with Hb A2 percentage (r = 0.286, t test 0.044), and Hb F percentage (r = 0.366, t test 0.009). Sensitivity of a score as above to select patients for screening, using a cut off score of 2 or above for females and a score of 3 or above for males was 84%. Specificity was 100%. This is higher than if using the current criteria. If people with red cell count > 5 × 1012/L were also selected sensitivity would increase up to 84%, and negative predictive value to 86%. Conclusion: Even when MCV and MCH are normal, people should be screened to exclude haemoglobin E hetrozygosity, if red cell count or RDW is higher than the reference range for the age. Furthermore, clinicians can apply a score as defined above and select patients for screening. Therefore a screening tool using red cell parameters would be cost effective in hospital settings as well as for mass screening programmes.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
红细胞指数作为血红蛋白E特性筛选工具的有效性评估:一项横断面研究
背景:血红蛋白E(HbE)是第二常见的结构型血红蛋白变体,由β珠蛋白基因突变引起,导致β珠蛋白链26位赖氨酸被谷氨酸取代。当与β地中海贫血共同遗传时,它成为一个主要的健康负担。目的:评估红细胞参数作为鉴定血红蛋白E性状的筛查工具的有效性,并利用红细胞参数制定一个评分,以帮助在人群筛查中鉴定血红蛋白E的性状。材料和方法:本研究对25个20至64岁的血红蛋白E性状和25个对照组进行了研究。在所有参与者的全血细胞计数分析和血红蛋白变异分析。参与者是在排除了所有影响红细胞指数的因素后选择的,如缺铁、维生素B12和叶酸缺乏、妊娠、肝病、甲状腺功能减退、慢性饮酒、糖尿病、二甲双胍治疗和近期输血。对两组男性和女性分别进行的所有血液学参数的比较分析。结果:对于血红蛋白E特征的病例,总平均血红蛋白A为67.9±6.4%,血红蛋白E为27.3±3.7%,血红蛋白F为0.3±1.1%,血红蛋白A2为2.6±3.1%,RCC为5.03±0.89×1012/L,血红蛋白12.6±1.9g/dl,MCV为77.4±9.4fl,MCH为25.4±3.9pg,MCHC为32.9±2.1g/dl,RDW为14.21±4%。血红蛋白E特征和正常对照组之间的血液学参数显示出统计学上的显著差异。血红蛋白E(p=4.83×10-53)、血红蛋白A(p=2.61×10-41)、血红蛋白F(p=0.01)、血红蛋白(p=0.042)、红细胞计数(p=0.001)、MCV(p=48.90×10-12)、MCH(p=5.5×10-13)、RDW(p=0.007)。血红蛋白E百分比与以下红细胞参数呈统计学显著正相关。Hb E和红细胞计数(r=0.445,t检验0.001),Hb E与红细胞分布宽度(r=0.345,t试验0.014)。血红蛋白E百分比与以下指标呈显著负相关。Hb E和MCV(r=(-)0.76,t检验0.000)Hb E与MCH(r=,t检验0.000),并与Hb A2百分比(r=0.286,t检验0.044)和Hb F百分比(r=0.366,t试验0.009)呈正相关。使用女性2分或以上和男性3分或以上的截断分数选择筛查患者的敏感性为84%。特异性为100%。这比使用当前条件时要高。如果红细胞计数>5×1012/L的人也被选中,灵敏度将提高到84%,阴性预测值将提高到86%。结论:即使在MCV和MCH正常的情况下,如果红细胞计数或RDW高于年龄的参考范围,也应进行筛查以排除血红蛋白E杂合性。此外,临床医生可以应用如上定义的评分,并选择患者进行筛查。因此,使用红细胞参数的筛查工具在医院环境和大规模筛查计划中都具有成本效益。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Case Report and Literature Review on Patient with Sticky Platelet Syndrome and a Series of It's Complications Correlation of Manual Peripheral Blood Smear Examination with RBC Indices and Histograms Obtained from an Automated Hematological Analyzer in Anemic Patients at Jimma Medical Center, Southwest Ethiopia, 2022 Wernicke's Encephalopathy: A Rare but Avoidable Neurological Complication Associated with Allogeneic Stem Cell Transplant Prevalence and Causes of Deferrals among Repeat Blood Donors in Dar es Salaam Tanzania The Relationship between Serum Ferritin and Platelet Count in Yemeni Blood Donors
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1